Bastiaan van der Baan's most recent trade in Lixte Biotechnology Holdings Inc was a trade of 25,000 Options to Purchase Common Stock done . Disclosure was reported to the exchange on June 30, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lixte Biotechnology Holdin... | Bastiaan van der Baan | Director | 30 Jun 2023 | 25,000 | 25,000 | - | - | Options to Purchase Common Stock | ||
| Lixte Biotechnology Holdin... | Bastiaan van der Baan | Director | 30 Jun 2023 | 10,000 | 10,000 | - | - | Options to Purchase Common Stock | ||
| Lixte Biotechnology Holdin... | Bastiaan van der Baan | Director | 30 Dec 2022 | 10,000 | 10,000 | - | 0.5 | 4,900 | Common Stock | |
| Lixte Biotechnology Holdin... | Bastiaan van der Baan | Director | 17 Jun 2022 | 250,000 | 250,000 | - | - | Options to Purchase Common Stock |